Skip to content
Christgiving
← Back to briefing

DR Congo: Two new candidate vaccines to join Ebola trial as treatment research advances

DR Congo: Two new candidate vaccines to join Ebola trial as treatment research advances
Photo: ReliefWeb · view original
FacebookXWhatsAppEmail

The recommendation marks the first time vaccines specifically designed to protect against Bundibugyo virus, the virus responsible for the current outbreak, will be evaluated during an outbreak of the disease. The two vaccine candidates are ChAdOx1, developed by the University of Oxford with the Se

Sources and story details